Partnership to leverage Caris’ market-leading molecular profiling offerings and enable broader research, increased pediatric trial opportunities and improved patient outcomes IRVING, Texas, March 5, 2024 /PRNewswire/ — Caris Life Sciences®(Caris), the leading next-generation AI TechBio…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.